StockData
Corbus Pharmaceuticals Holdings, Inc. logo

Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock

CRBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$2.75−0.26 (-8.80%)

Close on Nov 18, 2026Market cap $53.09MP/E –Yield –

Corbus Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Corbus Pharmaceuticals's price to sales ratio was 135.6× on Jul 29, 2022, against 60.7× a year earlier. Over the last 5 years it ranged from 8.5× to 169.0×, with a median of 75.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Jul 29, 2022135.6×+85.5
2021Dec 31, 202150.1×+32.5
2020Dec 31, 202017.6×+7.6
2019Dec 31, 20199.9×−105.5
2018Dec 31, 2018115.5×−11.2
2017Dec 29, 2017126.7×−69.0
2016Dec 30, 2016195.6×–

More Corbus Pharmaceuticals figures

See a number that looks wrong?